000			01625nam a22004935i 4500
001			978-3-642-17969-3
003			DE-He213
005			20130515022139.0
007			cr nn 008mamaa
008			110621s2011 gw | s |||| 0|eng d
020			_a9783642179693 _9978-3-642-17969-3
024	7		_a10.1007/978-3-642-17969-3 _2doi
050		4	_aRM1-950
072		7	_aMMG _2bicssc
072		7	_aMED071000 _2bisacsh
082	0	4	_a615 _223
100	1		_aFrancis, Sharron H.
245	1	0	_aPhosphodiesterases as Drug Targets _h[electronic resource] / _cedited by Sharron H. Francis, Marco Conti, Miles D. Houslay.
260			_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2011.
300			_bdigital.
490	0		_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v204
650		0	_aMedicine.
650		0	_aToxicology.
650		0	_aBiochemistry.
650		0	_aEnzymes.
650		0	_aPost-translational modification of proteins.
650		0	_aCytology.
650	1	4	_aBiomedicine.
650	2	4	_aPharmacology/Toxicology.
650	2	4	_aMedicinal Chemistry.
650	2	4	_aProtein Structure.
650	2	4	_aEnzymology.
650	2	4	_aPosttranslational Modification.
650	2	4	_aCell Physiology.
700	1		_aConti, Marco.
700	1		_aHouslay, Miles D.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783642179686
830		0	_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v204
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-642-17969-3
912			_aZDB-2-SBL
999			_c84573 _d84573